NCT00004083View on ClinicalTrials.gov

Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 1999

Primary Completion Date

December 31, 1999

Conditions
Ovarian Cancer
Interventions
DRUG

cisplatin liposomal

Trial Locations (1)

10016

Kaplan Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER

NCT00004083 - Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer | Biotech Hunter | Biotech Hunter